Gene Patenting Update

UPI reported an update earlier this week on Association for Molecular Pathology, et al. v. USPTO--the Myriad human gene patenting case:

Genetic Engineering & Biotechnology News in a March 23 analysis said the uncertainty in the United States over Myriad's patents, and similar challenges in Australia -- where legislation is being introduced to prevent the patenting of human genes and biological materials that are substantially identical to that in nature, even if they are isolated -- should not affect the status of gene patents in Europe "even if additional requirements are imposed on patents claiming genetic material."

This one is worth watching. Most likely the issue will go to the Supreme Court next year.